Alizurol purple

CAS No. 81-48-1

Alizurol purple ( NSC 2856; NSC2856; NSC-2856; Solvent Violet 13 )

Catalog No. M27234 CAS No. 81-48-1

Alizurol purple is an agent of biochemical.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 47 Get Quote
10MG 70 Get Quote
25MG 158 Get Quote
50MG 267 Get Quote
100MG 471 Get Quote
500MG 1006 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Alizurol purple
  • Note
    Research use only, not for human use.
  • Brief Description
    Alizurol purple is an agent of biochemical.
  • Description
    Alizurol purple is an agent of biochemical.
  • Synonyms
    NSC 2856; NSC2856; NSC-2856; Solvent Violet 13
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    81-48-1
  • Formula Weight
    329.4
  • Molecular Formula
    C21H15NO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc1ccc(Nc2ccc(O)c3C(=O)c4ccccc4C(=O)c23)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Song X, Chen J, Zhao M, Zhang C, Yu Y, Lonard DM, Chow DC, Palzkill T, Xu J, O'Malley BW, Wang J. Development of potent small-molecule inhibitors to drug the undruggable steroid receptor coactivator-3. Proc Natl Acad Sci U S A. 2016 May 3;113(18):4970-5.
molnova catalog
related products
  • Dipsanoside B

    Dipsanoside B is a natural product.

  • UBP 310

    GLUK5 kainate receptor antagonist.

  • ATI-2341 TFA (133787...

    ATI-2341 is an effective functionally selective allosteric agonist for the c-x-c chemokine receptor type 4 (CXCR4), which ACTS as a biased ligand in favor of G G G G G 1 activation instead of G G G G G 13.ATI-2341 activates the inhibitory heterotrimer G protein (Gi) to promote inhibition of cAMP production and induce calcium mobilization.ATI-2341 is an effective mobilization agent for myeloid polymorphonuclear neutrophils (PMNs) and hematopoietic stem and progenitor cells (HSPCs).